Skip to main content
OpenTrials

Clinical trial condition

Schizophrenia, Treatment-Resistant

Explore clinical trials studying Schizophrenia, Treatment-Resistant. Study availability and eligibility vary by location and protocol.

30 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Schizophrenia, Treatment-Resistant trial results

Recruiting

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

NCT07184619

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, +2 more
Locations
  • UCLA DGSOM, UCLA Health, UCLA Semel Institute Los Angeles, California, United States
  • University of Miami, Miller School of Medicine; Jackson Behavioral Health Hospital Miami, Florida, United States
  • Grady Behavioral Health Center, -Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine Atlanta, Georgia, United States
  • Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Recruiting

Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial

NCT06456983

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, +2 more
Locations
  • Dept. of Psychiatry, RWTU Aachen Aachen, Germany
  • Dept. of Psychiatry, University of Augsburg Augsburg, Germany
  • Klinik für Psychiatrie, Göppingen Göppingen, Germany
  • Departmet of Psychiatry, University Medical Center Göttingen Göttingen, Germany
View all 14 locations
View Trial Details

Related conditions